Charles J. Yeo, MD, FACS

Charles J. Yeo, MD, FACS

Contact Dr. Yeo

1015 Walnut Street
Curtis Building, Suite 620
Philadelphia, PA 19107

(215) 955-8643
(215) 923-6609 fax

Most Recent Peer-reviewed Publications

  1. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential
  2. Enhancing Patient Outcomes while Containing Costs after Complex Abdominal Operation: A Randomized Controlled Trial of the Whipple Accelerated Recovery Pathway
  3. Host IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancers
  4. César roux—the mind behind the roux-en-Y
  5. Surgical history: Charles heber mcburney-mcburney and his point to make
  6. Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer
  7. Bernard J. Miller, M.D., Sc.D. (Hon.) (1918-2007): The life and scientific contributions of a crucial figure in the development of the heart-lung machine
  8. The Legend of George J. Willauer, M.D. (1896-1977)
  9. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
  10. Symptom clusters in patients with pancreatic cancer undergoing surgical resection: Part i
  11. Symptom clusters in patients with pancreatic cancer undergoing surgical resection: Part II
  12. Comprehensive Multicenter Graduate Surgical Education Initiative Incorporating Entrustable Professional Activities, Continuous Quality Improvement Cycles, and a Web-Based Platform to Enhance Teaching and Learning
  13. Algernon Brashear Jackson, M.D.: A Pioneer for Community and Minority Advocacy
  14. Algernon Brashear Jackson, M.D.: A pioneer for community and minority advocacy
  15. The Combination of Pancreas Texture and Postoperative Serum Amylase in Predicting Pancreatic Fistula Risk
  16. The combination of pancreas texture and postoperative serum amylase in predicting pancreatic fistula risk
  17. Precision medicine based on next-generation sequencing and master controllers
  18. Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
  19. A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
  20. Gerald J. Marks, M.D., FACS (1925-), founder of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES)